Literature DB >> 11138779

Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines.

Y Sotsios1, S G Ward.   

Abstract

Chemokines can couple to distinct signalling pathways that have been demonstrated to mediate not only migration, but also cell growth and transcriptional activation. One particular signalling pathway, namely that controlled by the lipid kinase phosphoinositide 3-kinase (PI3K), has been the focus of much attention with respect to its activation by chemokine receptors and the role it plays in regulating cell migration. Identification of PI3K is arguably one of the most exciting recent developments in biochemical signalling. Pharmacological and genetic studies have now convincingly shown that both CC and CXC chemokines stimulate PI3K-dependent chemotaxis of inflammatory cells such as eosinophils, macrophages, neutrophils and T lymphocytes. This review considers the role of specific sub-classes of PI3Ks (e.g. the p85/p110 heterodimer, PI3Kgamma and PI3K-C2alpha) as well as their downstream effector targets in mediating chemokine-stimulated cell migration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11138779     DOI: 10.1034/j.1600-065x.2000.17712.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  38 in total

Review 1.  Understanding selective trafficking of lymphocyte subsets.

Authors:  M Heydtmann; D H Adams
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

Authors:  J H Wain; J A Kirby; S Ali
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

Review 3.  Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function.

Authors:  Hanne L Ostergaard; Tara L Lysechko
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer.

Authors:  Mikael Herlevsen; Gary Oxford; Celeste Ptak; Jeffrey Shabanowitz; Donald F Hunt; Mark Conaway; Dan Theodorescu
Journal:  Biochem Biophys Res Commun       Date:  2006-11-21       Impact factor: 3.575

Review 5.  Establishment and maintenance of cell polarity during leukocyte chemotaxis.

Authors:  Concepción Gómez-Moutón; Santos Mañes
Journal:  Cell Adh Migr       Date:  2007-04-06       Impact factor: 3.405

6.  p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.

Authors:  Aurore Saudemont; Fabien Garçon; Hakim Yadi; Marta Roche-Molina; Nayoung Kim; Anne Segonds-Pichon; Alfonso Martín-Fontecha; Klaus Okkenhaug; Francesco Colucci
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

7.  Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche.

Authors:  David W Infanger; YouJin Cho; Brina S Lopez; Sunish Mohanan; S Chris Liu; Demirkan Gursel; John A Boockvar; Claudia Fischbach
Journal:  Cancer Res       Date:  2013-10-11       Impact factor: 12.701

8.  Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease.

Authors:  LeShara M Fulton; Nicholas A Taylor; James M Coghill; Michelle L West; Niko Föger; James E Bear; Albert S Baldwin; Angela Panoskaltsis-Mortari; Jonathan S Serody
Journal:  Eur J Immunol       Date:  2014-06       Impact factor: 5.532

9.  Delineating the signals by which repetitive deformation stimulates intestinal epithelial migration across fibronectin.

Authors:  Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; Brittany Alston; Thomas L Flanigan; Marc D Basson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

10.  Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.

Authors:  Lorella Bonaccorsi; Sara Marchiani; Monica Muratori; Gianni Forti; Elisabetta Baldi
Journal:  J Cancer Res Clin Oncol       Date:  2004-07-16       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.